Release of neuropeptide FF (FLFQPQRF-NH 2) from rat spinal cord

Abstract

Neuropeptide FF (FLFQPQRF-NH 2), originally isolated from bovine brain, is an FMRF-NH 2-like peptide with morphine-modulating activity. Neuropeptide FF (NPFF) is highly localized in the dorsal spinal cords where there are also specific NPFF binding sites. Furthermore, there have been studies indicating that NPFF may participate in the regulation of pain threshold in the spinal cord. However, whether NPFF can be released from the spinal cord is not known. The present experiments, using an in vitro superfusion of an isolated whole rat spinal cord, demonstrated that high concentrations of KCl or substance P caused a release of NPFF immunoreactive material (IR) from the spinal cord into the perfusion medium in a calcium-dependent manner. Substance P (1–11) also produced a detectable release of NPFF-IR in vivo although the response was quite variable. The released NPFF-IR was analyzed by an HPLC study and found to consist of NPFF and other minor immunoreactive peptides. Further studies with substance P-related peptides showed that the in vitro release of NPFF-IR could also be induced by substance P (1–7) but not by [pGlu 5,Me-Phe 8,Sar 9]-substance P(5–11) or substance K. These results suggest that the specific substance P receptor (SP-N), which is recognized by both substance P (1–11) and substance P(1–7) rather than the tachykinin receptor, is involved in NPFF secretion from the spinal cord. In view of the role of substance P(1–11) and substance P(1–7) in sensory transmission, the results of this study further support the role of NPFF in the modulation of antinociception in the spinal cord.